新萊應材(300260.SZ):泛半導體真空產品的AdvanTorr品牌以及氣體產品的NanoPure品牌均可以應用到泛半導體產業鏈上下遊中
格隆匯7月16日丨新萊應材(300260.SZ)在互動平臺表示,公司一直專注於高純及超高純潔淨應用材料的研發、製造與銷售,產品主要應用於食品安全、生物醫藥和泛半導體等業務領域。公司的半導體真空系統和氣體系統可以服務於相關的泛半導體設備供應商和終端製造商,設備端客戶以直供的方式與客戶合作,在廠務端一般通過工程公司間接供給(最終用戶指定)。公司的泛半導體真空產品的AdvanTorr品牌以及氣體產品的NanoPure品牌均可以應用到泛半導體產業鏈上下遊中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.